Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.44
0.325.23%
At close: -
$6.57
0.132.02%
After Hours: May 23, 4:10 PM EDT
Comments
Loading...
Fulcrum Therapeutics Stock Price, Quotes and Forecasts
FULCNASDAQ
Fulcrum Therapeutics (FULC) Forecast
NewsEarningsFulcrum Therapeutics (FULC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Fulcrum Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:FULC | Benzinga
Explore Fulcrum Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FULC.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Fulcrum Therapeutics (FULC) stock?
You can purchase shares of Fulcrum Therapeutics (NASDAQ:FULC) through any online brokerage.
Who are Fulcrum Therapeutics (FULC) competitors?
Other companies in Fulcrum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and SNDL (NASDAQ:SNDL).
What is the forecast, or price target, for Fulcrum Therapeutics (FULC) stock?
Fulcrum Therapeutics has a consensus price target of $8.31.
What is the current price for Fulcrum Therapeutics (FULC)?
The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $6.57 last updated May 23, 2025 at 4:10 PM EDT.
Does Fulcrum Therapeutics (FULC) pay a dividend?
There are no upcoming dividends for Fulcrum Therapeutics.
When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?
Fulcrum Therapeutics’s Q2 earnings are confirmed for Wednesday, July 30, 2025.
Is Fulcrum Therapeutics (FULC) going to split?
There is no upcoming split for Fulcrum Therapeutics.
What sector and industry does Fulcrum Therapeutics (FULC) operate in?
Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
